Hepatocellular carcinoma in cats: treatment, prognosis and clinical trials
Cats · USA & Canada
Understanding hepatocellular carcinoma
Feline hepatocellular carcinoma is a primary cancer of liver cells. A solitary liver mass that can be removed is a very different situation from multifocal or diffuse disease. Imaging is used to determine whether the tumor is truly localized and whether surgery is realistic.
What does the prognosis look like?
A cat with one removable liver tumor may do well after surgery. One 19-cat surgical study found a typical survival time of about 2.4 years, and a larger multicenter group reported a very similar figure. These were selected retrospective populations, not promises. Cancer involving several parts of the liver, important structures or distant organs is much harder to control.
What matters next
The most useful first question is whether there is one removable liver mass or multifocal or invasive disease. A large solitary mass is not automatically untreatable. Imaging should define the involved liver lobes, major vessels and any visible spread before surgery is ruled in or out.
Where are you now?
There is one apparently resectable liver mass
Ask for surgical review of the mass and its relationship to major vessels. A solitary resectable tumor should not be grouped with multifocal or diffuse liver cancer when discussing prognosis or treatment.
Liver lobectomy has already been done
Review histopathology, margins, and staging. Follow-up should be based on the actual tumor type and completeness of removal rather than assuming every liver carcinoma needs chemotherapy.
There are multiple or diffuse liver lesions
The favorable assumptions from a solitary resectable mass do not apply. Confirm diagnosis and liver function before considering biopsy, systemic treatment, or supportive care.
The mass is not resectable
Ask why: location, vascular invasion, multifocal disease, metastasis, or the cat’s overall condition. Those reasons lead to different realistic alternatives.
If you are waiting for oncology
Clarify whether this is a solitary resectable liver mass or multifocal/diffuse disease. Surgical anatomy is central, and favorable outcomes from solitary resectable tumors should not be generalized to diffuse liver cancer.
Questions to ask your oncologist
- Is this a solitary resectable HCC?
- What major vessels or liver structures limit surgery?
- If surgery is not feasible, what evidence supports the proposed alternative in cats?
How the diagnosis may appear in the record
Ask whether imaging and pathology describe a solitary massive hepatocellular carcinoma or nodular, multifocal, diffuse, or invasive liver disease. Those patterns have very different surgical possibilities. The report should also clarify involved lobes, vascular invasion, margins after surgery, and visible spread.
Changes to watch for at home
Report reduced appetite, vomiting, abdominal swelling or pain, weakness, weight loss, jaundice, or pale gums. Collapse, marked abdominal distension, severe weakness, or suspected internal bleeding is urgent. Large tumors can cause mechanical or bleeding problems even before liver function fails.
How it is usually treated
A solitary resectable hepatocellular carcinoma is usually treated with liver lobectomy and can have prolonged control. Multifocal, diffuse, invasive or metastatic liver cancer requires an individualized plan rather than the same surgical approach.
What can affect treatment choices
Solitary versus multifocal or diffuse disease, vascular anatomy, resectability, liver function and spread matter more than the cancer label alone.
Tests that may matter
Abdominal ultrasound or CT helps define which liver lobes are involved, the relationship to major vessels and whether surgery is realistic. Chest staging and assessment for abdominal spread are reasonable before major surgery. Tissue diagnosis matters because different liver cancers behave differently.